richard finn, md, shares his thoughts on the role of systemic therapy in hcc
Published 5 years ago • 132 plays • Length 1:12
Download video MP4
Download video MP3
Similar videos
-
1:30
richard finn, md, outlines the role of tace with systemic therapy in hcc
-
2:13
richard s. finn, md, offers opinion on the role of frontline atezolizumab bevacizumab in hcc
-
1:35
richard finn, md: systemic therapy in a uhcc patient
-
1:59
richard s. finn, md, offers opinion on the broader role of i-o in the management of hcc
-
3:56
richard finn, md: possible systemic therapy in a uhcc patient
-
1:25
richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
-
4:56
liver cancer - causes, signs & symptoms, diagnosis, treatment | dr tan hon lyn (medical oncologist)
-
47:42
immune therapy in hepatocellular carcinoma
-
35:11
why cancer rates are increasing - and the best strategy to remain cancer-free
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
2:17
richard finn, md, speculates on combined checkpoint inhibition in hcc & biliary tract cancer
-
3:07
richard finn, md: interventional radiology and local/regional therapy
-
2:55
richard s. finn, md, regarding outcomes from keynote 240 in 1st line hcc
-
2:18
dr. finn on biomarkers of response in hcc
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
0:50
richard s. finn, md, speculates on the next phase of hcc management and research
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
1:08
richard finn, md: use of selective internal radiation therapy in a uhcc patient
-
1:05:05
hcc: optimizing outcomes with new and emerging treatment approaches
-
2:11
dr. finn on the rationale for the phase iii keynote-240 trial in hcc
Clip.africa.com - Privacy-policy